Skip to main content

Hugo Fernando Avalos Bogado

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Hugo Fernando Avalos Bogado

Institutions of which they are part

Predoctoral researcher
Rheumatology
Vall Hebron Institut de Recerca

Projects

Caracterización de las células patogénicas del músculo y piel de pacientes con Dermatomiositis y Síndrome Antisintetasa y estudio de aplicabilidad traslacional.

IP: Ernesto Trallero Araguas
Collaborators: Albert Selva O'Callaghan, Raul Tortosa Mendez, Albert Gil Vila, Gloria Aparicio Español, Adria Aterido Ballonga, Hugo Fernando Avalos Bogado
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI22/00708
Duration: 01/01/2023 - 31/12/2025

Related news

Funded by the European Union, this project coordinated by the Vall d'Hebron Research Institute (VHIR) seeks to develop more effective therapies by creating new combinations of existing drugs

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Related professionals

Olalla Bagüés Bedoya

Olalla Bagüés Bedoya

Director/a d'Àrea
Human Resources Directorate
Read more
Raquel Ibañez Ferrer

Raquel Ibañez Ferrer

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more
Shirley Guzmán Avilés

Shirley Guzmán Avilés

Tècnic/a Grau Superior
External Strategy Directorate
Read more
Rodrigo Vasquez Mercado

Rodrigo Vasquez Mercado

Research technician
Microbiology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.